Perceptions and attitudes about preexposure prophylaxis among seronegative partners and the potential of sexual disinhibition

Southern Medical Journal

Volumn 106, Issue 10, 2013, Pages 558-564

  Tripathi, Avnish ^a,b   Whiteside, Y Omar ^a   Duffus, Wayne A ^a  

^a UNIVERSITY OF SOUTH CAROLINA   (United States)

^b UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

Biomedical strategy; Discordant couples; Human immunodeficiency virus prevention; Preexposure prophylaxis; Seronegative partners

Indexed keywords

ADULT; ARTICLE; ATTITUDE TO SEXUALITY; CONDOM USE; CULTURAL FACTOR; FEMALE; HETEROSEXUALITY; HIGH RISK BEHAVIOR; HUMAN; INFECTION PREVENTION; MALE; MEN WHO HAVE SEX WITH MEN; PREEXPOSURE PROPHYLAXIS; RISK REDUCTION; SEXUAL BEHAVIOR; SEXUAL DISINHIBITION; SEXUAL PRACTICE; UNITED STATES; UNSAFE SEX;

ADOLESCENT; ADULT; ANTI-HIV AGENTS; CONDOMS; CULTURE; FEMALE; HEALTH CARE SURVEYS; HETEROSEXUALITY; HIV INFECTIONS; HOMOSEXUALITY, MALE; HUMANS; LOGISTIC MODELS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATIENT ACCEPTANCE OF HEALTH CARE; PILOT PROJECTS; SELF REPORT; SOCIOECONOMIC FACTORS; SOUTH CAROLINA; UNSAFE SEX; YOUNG ADULT;

EID: 84885609047     PISSN: 00384348     EISSN: 15418243     Source Type: Journal    
DOI: 10.1097/SMJ.0000000000000010     Document Type: Article

References (33)

1. Gostin LO, Kim SC. Ethical allocation of preexposure HIV prophylaxis. JAMA 2011;305:191-192.
2. AVAC. PrEP resources. http://www.avac.org/ht/d/sp/i/354/pid/354. Accessed May 12, 2011.
3. Michael NL. Oral preexposure prophylaxis for HIVVanother arrow in the quiver? N Engl J Med 2010;363:2663-2665.
4. Myers GM, Mayer KH. Oral preexposure anti-HIV prophylaxis for highrisk U.S. populations: current considerations in light of newfindings. AIDS Patient Care STDS 2011;25:63-71.
5. Thigpen MC, Rose CE, Paxton LA. Antiretroviral preexposure prophylaxis for HIV prevention. N Engl J Med 2013;368:82-83.
6. Grant RM, Lama JR, Anderson PL, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med 2010;363:2587-2599.
7. Baeten J, Celum C. Antiretroviral pre-exposure prophylaxis for HIV-1 prevention among heterosexual African men and women: the Partners PrEP Study. http://www.hptn.org/web%20documents/WHRC/PartnersPrep Study18Jul2011.pdf. Accessed January 3, 2012.
8. Van Damme L, Cornell A, Ahmed K, et al. Preexposure prophylaxis for HIV infection among African women. N Engl J Med 2012;367:411-422.
9. Centers for Disease Control and Prevention. PrEP: a new tool for HIV prevention. http://www.cdc.gov/hiv/prep/pdf/PREPfactsheet.pdf. Published August 2012. Accessed January 3, 2013.
10. Centers for Disease Control and Prevention. Update to interim guidance for preexposure prophylaxis (PrEP) for the prevention of HIV infection: PrEP for injecting drug users. MMWR Morb Mortal Wkly Rep 2013;62: 463-465.
11. Brooks RA, Kaplan RL, Lieber E, et al. Motivators, concerns, and barriers to adoption of preexposure prophylaxis for HIV prevention among gay and bisexual men in HIV-serodiscordant male relationships. AIDS Care 2011;23:1136-1145.
12. Voetsch AC, Heffelfinger JD, Begley EB, et al. Knowledge and use of preexposure and postexposure prophylaxis among attendees of Minority Gay Pride events, 2005 through 2006. J Acquir Immune Defic Syndr 2007;46:378-380.
13. Whiteside YO, Harris T, Scanlon C, et al. Self-perceived risk of HIV infection and attitudes about preexposure prophylaxis among sexually transmitted disease clinic attendees in South Carolina. AIDS Patient Care STDs 2011;25:365-370.
14. Tripathi A, Ogbuanu C, Monger M, et al. Pre-exposure prophylaxis for HIV infection: healthcare providers' knowledge, perception, and willingness to adopt future implementation in the southern US. South Med J 2012;105:199-206.
15. Kim SC, Becker S, Dieffenbach C, et al. Planning for pre-exposure prophylaxis to prevent HIV transmission: challenges and opportunities. J Int AIDS Soc 2010;13:24.
16. Garcia-Lerma JG, Paxton L, Kilmarx PH, et al. Oral pre-exposure prophylaxis for HIV prevention. Trends Pharmacol Sci 2010;31:74-81.
17. Paxton LA, Hope T, Jaffe HW. Pre-exposure prophylaxis for HIV infection: what if it works? Lancet 2007;370:89-93.
18. Cohen MS, Chen YQ, McCauley M, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med 2011;365:493-505.
19. SAS. Usage Note 32471. How do I test for equal variances, collinearity, or normality in logit, probit, poisson or other generalized linear models? Knowledge base/samples and SAS notes. http://support.sas.com/kb/32/471. Accessed October 17, 2011.
20. Mimiaga MJ, Case P, Johnson CV, et al. Preexposure antiretroviral prophylaxis attitudes in high-risk Boston area men who report having sex with men: limited knowledge and experience but potential for increased utilization after education. J Acquir Immune Defic Syndr 2009; 50:77-83.
21. Golub SA, Kowalczyk W, Weinberger CL, et al. Preexposure prophylaxis and predicted condom use among high-risk men who have sex with men. J Acquir Immune Defic Syndr 2010;54:548-555.
22. Vanable PA, Carey MP, Brown JL, et al. What HIV-positive MSM want from sexual risk reduction interventions: findings from a qualitative study. AIDS Behav 2012;16:554-563.
23. Ngure K, Mugo N, Celum C, et al. A qualitative study of barriers to consistent condom use among HIV-1 serodiscordant couples in Kenya. AIDS Care 2012;24:509-516.
24. van der Straten A, Gomez CA, Saul J, et al. Sexual risk behaviors among heterosexual HIV serodiscordant couples in the era of post-exposure prevention and viral suppressive therapy. AIDS 2000;14:F47-F54.
25. Elam G, Macdonald N, Hickson FC, et al. Risky sexual behaviour in context: qualitative results from an investigation into risk factors for seroconversion among gay men who test for HIV. Sex Transm Infect 2008;84:473-477.
26. Beckerman NL, Letteney S, Lorber K. Key Emotional issues for couples of mixed HIV status. Soc Work Health Care 2000;31:25-41.
27. Desai K, Sansom SL, Ackers ML, et al. Modeling the impact of HIV chemoprophylaxis strategies among men who have sex with men in the United States: HIV infections prevented and cost-effectiveness. AIDS 2008;22:1829-1839.
28. Holt M, Murphy DA, Callander D, et al. Willingness to use HIV preexposure prophylaxis and the likelihood of decreased condom use are both associated with unprotected anal intercourse and the perceived likelihood of becoming HIV positive among Australian gay and bisexual men. Sex Transm Infect 2012;88:258-263.
29. Grohskopf L, Gvetadze R, Pathak S, et al. Preliminary analysis of biomedical data from the phase II clinical safety trial of tenofovir disoproxil fumarate (TDF) for HIV-1 pre-exposure prophylaxis (PrEP) among US men who have sex with men (MSM). http://pag.aids2010.org/Abstracts. aspx?AID=17777. Accessed August 27, 2013.
30. García-Lerma JG, Otten RA, Qari SH, et al. Prevention of rectal SHIV transmission in macaques by daily or intermittent prophylaxis with emtricitabine and tenofovir. PLoS Med 2008;5:e28.
31. Underhill K, Operario D, Mimiaga MJ, et al. Implementation science of pre-exposure prophylaxis: preparing for public use. Curr HIV/AIDS Rep 2010;7:210-219.
32. Underhill K, Operario D, Skeer M, et al. Packaging PrEP to prevent HIV: an integrated framework to plan for pre-exposure prophylaxis implementation in clinical practice. J Acquir Immune Defic Syndr 2010;55:8-13.
33. Centers for Disease Control and Prevention. CDC's clinical studies of preexposure prophylaxis for HIV prevention. http://www.cdc.gov/hiv/prep/ resources/qa/index.htm. Published 2010. Accessed January 4, 2010.